{
  "id": "6273ec14d351e2e9",
  "title": "Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE - 3 Topline Data",
  "description": "20260120T144500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/capricor-therapeutics-provides-regulatory-update-on-deramiocel-bla-following-fda-review-of-hope-3-topline-data/2261987",
  "published_at": "20260120T144500Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "regulatory"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/capricor-therapeutics-provides-regulatory-update-on-deramiocel-bla-following-fda-review-of-hope-3-topline-data/2261987",
    "url_mobile": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/capricor-therapeutics-provides-regulatory-update-on-deramiocel-bla-following-fda-review-of-hope-3-topline-data/2261987/amp",
    "title": "Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE - 3 Topline Data",
    "seendate": "20260120T144500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/20/906304.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}